The management of severe emergence agitation using droperidol

Anaesthesia

Volumn 61, Issue 11, 2006, Pages 1112-1115

  Hatzakorzian, Roupen ^a   Li Pi Shan, W ^a   Cote A V ^a   Schricker, T ^a   Backman, S B ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; CARBAMAZEPINE; CLONAZEPAM; DESFLURANE; DROPERIDOL; FENTANYL; GLYCOPYRRONIUM BROMIDE; LIDOCAINE; MIDAZOLAM; NEOSTIGMINE; OXYGEN; PROPOFOL; ROCURONIUM; SEVOFLURANE; SUFENTANIL; SUXAMETHONIUM;

ADOLESCENT; ADULT; AGGRESSION; AGITATION; ANESTHESIA COMPLICATION; ANESTHETIC RECOVERY; ARTICLE; CASE REPORT; DISEASE SEVERITY; DISORIENTATION; DRUG EFFICACY; GENERAL ANESTHESIA; HUMAN; MALE; MORBID OBESITY; MORBIDITY; PATIENT ATTITUDE; POSTOPERATIVE PERIOD; RESPIRATION DEPRESSION; RESTLESSNESS;

ADJUVANTS, ANESTHESIA; ADOLESCENT; ADULT; ANESTHESIA RECOVERY PERIOD; DROPERIDOL; HUMANS; MALE; PSYCHOMOTOR AGITATION; TREATMENT OUTCOME;

EID: 33750043755     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2006.04791.x     Document Type: Article

References (24)

1. Backman SB, Bondy RB, Deschamps A, Moore A, Schricker T. Perioperative considerations for anesthesia. In: Souba WW, Fink MP, Jurkovich GJ, et al., eds. ACS Surgery. New York: WebMD, 2004:36-49.
2. Voepel-Lewis T, Malviya S, Tait AR. A prospective cohort study of emergence agitation in the pediatric postanesthesia care unit. Anesthesia and Analgesia 2003; 96:1625-30.
3. Lepousé C, Lautner CA, Liu L, Gomis P, Leon A. Emergence delirium in the post-anaesthesia care unit. British Journal of Anaesthesia 2006; 96: 747-53.
4. Eckenhoff JE, Kneale DH, Dripps RD. The incidence and etiology of postanesthetic excitement: A clinical survey. Anesthesiology 1961; 22: 667-73.
5. Cole JW, Murray DJ, McAllister JD, Hirshberg GE. Emergence behaviour in children: Defining the incidence of excitement and agitation following anaesthesia. Paediatric Anaesthesia 2002; 12: 442-7.
6. Martin J. Postanaesthesia excitation. Paediatric Anaesthesia 2002; 12: 293-5.
7. Aono J, Ueda W, Mamiya K, Takimoto E, Manabe M. Greater incidence of delirium during recovery from sevoflurane anesthesia in preschool boys. Anesthesiology 1997; 87: 1298-300.
8. Cravero JP, Beach M, Dodge CP, Whalen K. Emergence characteristics of sevoflurane compared to halothane in pediatric patients undergoing bilateral pressure equalization tube insertion. Journal of Clinical Anesthesia 2000; 12: 397-401.
9. White PF. Droperidol: A cost-effective antiemetic for over thirty years. Anesthesia and Analgesia 2002; 95: 789-90.
10. White PF, Watcha MF. Postoperative nausea and vomiting: Prophylaxis versus treatment. Anesthesia and Analgesia 1999; 89: 1337-9.
11. Watcha MF. The cost-effective management of postoperative nausea and vomiting. Anesthesiology 2000; 92: 931-3.
12. Thomas H, Schwartz E, Petrilli R. Droperidol versus haloperidol for chemical restraint of agitated and combative patients. Annals of Emergency Medicine 1992; 21: 407-13.
13. Richards JR, Derlet RW, Duncan DR. Chemical restraint for the agitated patient in the emergency department: Lorazepam versus droperidol. Journal of Emergency Medicine 1998; 16: 567-73.
14. Knott JC, Taylor DM, David JC. Randomized control trial comparing intravenous midazolam and droperidol for sedation of the acutely agitated patient in the emergency department. Annals of Emergency Medicine 2006; 47: 61-7.
15. Prokocimer P, Delavaut E, Rey F, Lefevre P, Mazze RI, Desmonts JM. Effects of droperidol on respiratory drive in humans. Anesthesiology 1983; 59: 113-6.
16. Stoelting RK, Hillier SC. Pharmacology and Physiology in Anesthetic Practice. 4th edn. Philadelphia: Lippincott, Williams & Wilkins, 2006: 413-9.
17. Ward DS. Stimulation of hypoxic ventilatory drive by droperidol. Anesthesia and Analgesia 1984; 63: 106-10.
18. FDA press office. FDA strengthens warnings for droperidol, 2001. http://www.fda.gov/bbs/topics/ANSWERS//ANS01123.html [accessed 24 June 2006].
19. Gan TJ, White PF, Scuderi PE, Watcha MF, Kovac A. FDA 'black box' warning regarding use of droperidol for postoperative nausea and vomiting: Is it justified? Anesthesiology 2002; 97: 287.
20. Habib AS, Gan TJ. Food and Drug Administration black box warning on the perioperative use of droperidol: A review of the cases. Anesthesia and Analgesia 2003; 96: 1377-9.
21. Shale JH, Shale CM, Mastin WD. A review of the safety and efficacy of droperidol for the rapid sedation of severely agitated and violent patients. Journal of Clinical Psychiatry 2003; 64: 500-5.
22. Kao LW, Kirk MA, Evers SJ, Rosenfeld SH. Droperidol, QT prolongation and sudden death: What is the evidence? Annals of Emergency Medicine 2003; 41: 546-58.
23. Horowitz BZ, Bizovi K, Moreno R. Droperidol - behind the black box warning. Academic Emergency Medicine 2002; 9: 615-8.
24. Committee for Proprietary Medicinal Products (CPMP). Points to consider: The assessment of the potential for QT interval prolongation by non-cardiovascular medicinal products. London: 17 December 1997. http://coresearch.biz/regulations/cpmp.pdf [accessed 25 June 2006].